CARA Cara Therapeutics Inc.

-0.08  -1%
Previous Close 12.48
Open 12.50
Price To book 3.70
Market Cap 404010414
Shares 32,581,485
Volume 773,592
Short Ratio 9.83
Av. Daily Volume 838,276

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 initiated September 2015. Placed on clinical hold February 2016. Clinical hold released April 2016 with enrollment resuming June 2016. Interim conditional power analysis conducted June 21, 2017 - completion of enrollment due 4Q 2017.
IV CR845
Acute pain
Phase 2b data released June 29, 2017 - trial failed.
Osteoarthritis (OA)
Phase 2/3 top-line data from Part A portion of trial released March 28, 2017 - endpoints met. Phase 3 trial to be initiated 4Q 2017.
IV CR845
Uremic pruritus

Latest News

  1. Cara Therapeutics Announces Participation in ANESTHESIOLOGY® 2017
  2. Cara Therapeutics to Present Data at Kidney Week 2017
  3. Cara Therapeutics Announces Successful End-of-Phase 2 Meeting with FDA for I.V. CR845 in Chronic Kidney Disease-Associated Pruritus
  4. Where Will Cara Therapeutics Be in 5 Years?
  5. Cara Therapeutics to Present at the Janney Montgomery Scott Osteoarthritis Pain Conference
  6. CARA Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : CARA-US : October 3, 2017
  7. CARA Therapeutics, Inc. – Value Analysis (NASDAQ:CARA) : September 12, 2017
  8. CARA Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : CARA-US : September 11, 2017
  9. Here's Why the Best Is Yet to Come for Cara Therapeutics, Inc.
  10. Stocks With Rising Relative Price Strength: Cara Therapeutics
  11. Here's Why Cara Therapeutics Rose 9.6% in August
  12. Upcoming Data Releases Fueled Strong Gains in These 2 Marijuana Stocks Last Week
  13. Surging Earnings Estimates Signal Good News for Cara Therapeutics (CARA)
  14. Big Investors Are Buying Cara Therapeutics Stock. Should You?
  15. Cara Therapeutics to Participate in September Medical Meetings
  16. Edited Transcript of CARA earnings conference call or presentation 3-Aug-17 8:30pm GMT
  17. This Marijuana Stock Skyrocketed Last Week, While 3 Others Plunged
  18. Today's Research Reports on Stocks to Watch: Cara Therapeutics, Inc. and Spectrum Pharmaceuticals
  19. 3 Things You Need to Know About Marijuana Stock Cara Therapeutics
  20. Why Cara Therapeutics Shares Are Surging 23% Today